Travere Therapeutics, Inc. (TVTX): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Older than the company's other figures. The latest Gross Profit is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$133.79M
Year ended 2023-12-31
Period endedGross ProfitChange YoYSource filing
2023-12-31$133.79Mn/a2026-02-19, From 2023-01-01